Document is current
Any future updates will be listed below
-
Authors
Gan, Wenhua
Song, Wenwen
Gao, Yujuan
Zheng, Xuexue
Wang, Fengjuan
Zhang, Zirui
Zen, Ke
Liang, Hongwei
Yan, Xin
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (81900062)
- License Information
-
More Information
Article History
Received: 24 December 2023
Accepted: 24 February 2024
First Online: 10 March 2024
Declarations
:
: This study was approved by the Human Research Ethics Committee of Nanjing Drum Tower Hospital (No. AF/SC-08/03.0). Animal experiments were performed in accordance with the Ethics Committee of China Pharmaceutical University.
: All authors agree to submit the article for publication.
: The authors declare that they have no competing interests. Wenhua Gan, Fengjuan Wang, Ke Zen and Hongwei Liang are co-inventors on the patent related to using the plasma exosomal circRNAs for IPF diagnosis and progression prediction. The application numbers are CN202110638461.1.
: During the preparation of this work the authors used chatGPT in order to improve language and readability. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.
